KCC2 overexpressed exosomes meditated spinal cord injury recovery in mice
Source abstract
Abstract
Abstract Exosomes show great potential in treating diseases of the central nervous system including spinal cord injury (SCI), still better engineered exosomes have more advantages. In this study, we purified exosomes from K+–Cl− co-transporter (KCC2) overexpressed bone marrow mesenchymal stem cells (ExoKCC2), to investigate the effect of ExoKCC2 on neural differentiation in vitro and the repairing function of ExoKCC2 in SCI mice in vivo. Compared to bone marrow mesenchymal stem cells (BMSC)-derived exosomes (Exo), ExoKCC2 could better promote neural stem cell differentiated into neurons, ameliorate the function recovery of SCI mice, and accelerate the neural regeneration at the lesion site. Altogether, engineered ExoKCC2 may prove to be an advantageous strategy for SCI treatment.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Extracellular vesicles in disease · MicroRNA in disease regulation · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (28)
Show source-provided references
1. Dense fibroadhesive scarring and poor blood vessel-maturation hamper the integration of implanted collagen scaffolds in an experimental model of spinal cord injury10.1088/1748-605X/ab5e52 ↗
2. A review of emerging neuroprotective and neuroregenerative therapies in traumatic spinal cord injury10.1016/j.coph.2021.08.009 ↗
3. Research advances of biomaterials-based microenvironment-regulation therapies for repair and regeneration of spinal cord injury10.1088/1748-605X/ac1d3c ↗
4. Therapeutic potential of mesenchymal stem cells (MSCs) and MSC-derived extracellular vesicles for the treatment of spinal cord injury10.3390/ijms222413672 ↗
5. Advanced approaches to regenerate spinal cord injury: the development of cell and tissue engineering therapy and combinational treatments10.1016/j.biopha.2021.112529 ↗
6. Mesenchymal stem cells and the neuronal microenvironment in the area of spinal cord injury10.4103/1673-5374.244778 ↗
7. Intravenous infusion of mesenchymal stem cells promotes functional recovery in a model of chronic spinal cord injury10.1016/j.neuroscience.2016.08.037 ↗
8. Phase 1 trial of autologous bone marrow stem cell transplantation in patients with spinal cord injury10.1155/2016/6768274 ↗
9. Exosomes derived from miR-26a-modified MSCs promote axonal regeneration via the PTEN/AKT/mTOR pathway following spinal cord injury10.1186/s13287-021-02282-0 ↗
10. Solid lipid nanoparticles loading with curcumin and dexanabinol to treat major depressive disorder10.4103/1673-5374.293155 ↗
11. Extracellular vesicles derived from CD73 modified human umbilical cord mesenchymal stem cells ameliorate inflammation after spinal cord injury10.1186/s12951-021-01022-z ↗
12. Emerging exosomes and exosomal MiRNAs in spinal cord injury10.3389/fcell.2021.703989 ↗
13. Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarization10.1186/s12974-020-1726-7 ↗
14. Black-phosphorus-incorporated hydrogel as a conductive and biodegradable platform for enhancement of the neural differentiation of mesenchymal stem cells10.1002/adfm.202000177 ↗
15. Neural stem cell-derived exosomes facilitate spinal cord functional recovery after injury by promoting angiogenesis10.1177/1535370219895491 ↗
16. hucMSC derived exosomes promote functional recovery in spinal cord injury mice via attenuating inflammation10.1016/j.msec.2018.04.006 ↗
17. Systemic administration of exosomes released from mesenchymal stromal cells attenuates apoptosis, inflammation, and promotes angiogenesis after spinal cord injury in rats10.1089/neu.2017.5063 ↗
18. Exosomes derived from bone mesenchymal stem cells repair traumatic spinal cord injury by suppressing the activation of A1 neurotoxic reactive astrocytes10.1089/neu.2018.5835 ↗
19. Intranasal delivery of mesenchymal stem cell derived exosomes loaded with phosphatase and tensin homolog siRNA repairs complete spinal cord injury10.1021/acsnano.9b01892 ↗
20. Exosomes derived from miR-133b-modified mesenchymal stem cells promote recovery after spinal cord injury10.3389/fnins.2018.00845 ↗
21. The therapeutic potential of neuronal K-Cl Co-transporter KCC2 in Huntington’s disease and its comorbidities10.3390/ijms21239142 ↗
22. Enhancing KCC2 activity decreases hyperreflexia and spasticity after chronic spinal cord injury10.1016/j.expneurol.2021.113605 ↗
23. Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications10.2147/IJN.S264498 ↗
24. Differential expression of circular RNAs in bone marrow-derived exosomes from essential thrombocythemia patients10.1002/cbin.11534 ↗
25. Surgery of experimental lesion of spinal cord equivalent to crush injury of fractured is location of spinal column10.1001/jama.1911.04260090100008 ↗
26. Reactivation of dormant relay pathways in injured spinal cord by KCC2 manipulations10.1016/j.cell.2018.06.005 ↗
27. Activation of 5-HT(2A) receptors restores KCC2 function and reduces neuropathic pain after spinal cord injury10.1016/j.neuroscience.2017.08.033 ↗
28. Rehabilitation decreases spasticity by restoring chloride homeostasis through the brain-derived neurotrophic factor-KCC2 pathway after spinal cord injury10.1089/neu.2019.6526 ↗